Oswaldo Cruz Foundation
Clinical trials sponsored by Oswaldo Cruz Foundation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- PrEP goes local: Community-Based HIV prevention trial launches in rio Results expected Dec 2026 (estimated)
- Could family clinics cure hepatitis c as well as specialists? Results expected Dec 2026 (estimated)
-
Could family clinics cure hepatitis c as well as specialists?
Disease control Recruiting nowThis trial tests whether treating hepatitis C in primary care clinics, with non-specialist doctors, works as well as the standard specialist care in Brazil. It also evaluates the use of rapid tests and self-testing to find more people with the infection. The goal is to see if a s…
Phase 4 • Sponsor: Oswaldo Cruz Foundation • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Texting for health: could a simple WhatsApp nudge boost HIV protection?
Prevention Recruiting nowThis study is testing whether weekly WhatsApp messages can help sexual and gender minorities in Brazil stay on track with HIV prevention (PrEP) and treatment (ART). Participants will be randomly assigned to receive either the messages or no messages for six months. The study will…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
PrEP goes local: Community-Based HIV prevention trial launches in rio
Prevention Recruiting nowThis study aims to make HIV prevention easier to access for underserved groups in Rio de Janeiro, such as gay and bisexual men, transgender women, and sex workers. Instead of requiring clinic visits, participants can get daily PrEP pills and support through community organization…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Rio study tests antibiotic after sex to stop STIs
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline shortly after sex can prevent bacterial STIs like syphilis, gonorrhea, and chlamydia. It involves 200 men, transgender women, and travestis in Rio de Janeiro who are at higher risk. Participants choose whether to use doxy…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
HIV prevention breakthrough? Twice-Yearly shot could replace daily pills
Prevention Recruiting nowThis study in Brazil offers young men who have sex with men, transgender, and non-binary people a choice between a daily pill or a twice-yearly injection to prevent HIV. Researchers will follow 1,500 participants for up to two years to see how well each option works in real life,…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC